Viewing Study NCT05607420

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-02-01 @ 3:14 AM
Study NCT ID: NCT05607420
Status: RECRUITING
Last Update Posted: 2025-08-24
First Post: 2022-10-25
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma
Sponsor: Cellectis S.A.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Non-Hodgkin Lymphoma (B-NHL) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None B-cell Non-Hodgkin Lymphoma (B-NHL) View
None Relapsed/Refractory B-NHL View
None Universal Chimeric Antigen Receptor T-Cell (UCAR-T) Therapy View
None Allogeneic View
None Transcription Activator-Like Effector Nuclease (TALEN®) View